Symposium “Biomedicine, bioinformatics and systems computational biology”

Symposium “Biomedicine, Bioinformatics and Systems Computational Biology” will consider advances in determining genetic predisposition and determination of the mechanisms of pathogenesis in the development of diseases and also the response (or lack thereof) to therapy using the full range of bioinformatiс technologies.

As clinical diagnostic methods become more complex, their correct implementation inevitably occurs within the framework of mathematical modeling based on digital technologies in the form of statistical and/or logical models. The pinnacle of this process is, modeling based on neural networks and machine learning. At the same time, the principle of “personalized medicine” can only be implemented using individual patient parameters: genomics, metabolomics, lifestyle, individual response to treatment methods, with monitoring of biomarkers (metabolomic parameters, functional monitoring using wearable devices, etc.). Variability in response to treatment depends on the genome of the patient, and in some cases, on the genome of the affected tissue (for example, in oncology).

Section “Gene expression and human diseases”

Julia Ragino, Research Institute of Internal and Preventive Medicine – Branch of Institute of Cytology and Genetics of SB RAS, Novosibirsk, Russia	Mikhail Voevoda, Research Institute of Internal and Preventive Medicine – Branch of Institute of Cytology and Genetics of SB RAS, Novosibirsk, Russia	Yuriy Orlov, I.M. Sechenov First Moscow State Medical University, Moscow, Russia; Institute of Cytology and Genetics of SB RAS, Novosibirsk, Russia

Section “Molecular Pathology, Diagnostics, and Therapeutics”

Maxim Korolev, Research Institute of Internal and Preventive Medicine – Branch of Institute of Cytology and Genetics of SB RAS, Novosibirsk, Russia	Vadim Klimontov, Research Institute of Internal and Preventive Medicine – Branch of Institute of Cytology and Genetics of SB RAS, Novosibirsk, Russia	Vladimir Konenkov, Research Institute of Internal and Preventive Medicine – Branch of Institute of Cytology and Genetics of SB RAS, Novosibirsk, Russia
Vladimir Zelman, University of South California, Los Angeles, USA	Andrey Pokrovskiy, Novosibirsk State University, Novosibirsk, Russia

Section “Gene and genome editing in modeling human pathological disease processes”

Suren Zakian, Institute of Cytology and Genetics of SB RAS, Novosibirsk, Russia	Irina Zakharova, Institute of Cytology and Genetics of SB RAS, Novosibirsk, Russia

Section “Innovative pharmacology”

Nariman Salakhutdinov, Institute of Organic Chemistry SB RAS, Novosibirsk, Russia	Tatiana Tolstikova, Institute of Organic Chemistry SB RAS, Novosibirsk, Russia	Mikhail Khvostov, N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch, Russian Academy of Sciences, Novosibirsk, Russia	Pavel Madonov, Research Institute of Internal and Preventive Medicine – Branch of Institute of Cytology and Genetics of SB RAS, Novosibirsk, Russia

Section “Tissue engineering”

Andrey Karpenko, Meshalkin National Medical Research Center, Novosibirsk, Russia	Larisa Antonova, Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russia

Section “Interstitial space and long extravascular drainage/transport pathways”

Andrey Letyagin, Research Institute of Internal and Preventive Medicine – Branch of Institute of Cytology and Genetics of SB RAS, Novosibirsk, Russia	Natalia Bgatova, Research Institute of Internal and Preventive Medicine – Branch of Institute of Cytology and Genetics of SB RAS, Novosibirsk, Russia